Abbott Laboratories SG&A Expenses 2010-2024 | ABT

Abbott Laboratories annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Abbott Laboratories sg&a expenses for the quarter ending September 30, 2024 were $2.895B, a 6.32% increase year-over-year.
  • Abbott Laboratories sg&a expenses for the twelve months ending September 30, 2024 were $11.514B, a 2.82% increase year-over-year.
  • Abbott Laboratories annual sg&a expenses for 2023 were $10.949B, a 2.66% decline from 2022.
  • Abbott Laboratories annual sg&a expenses for 2022 were $11.248B, a 0.67% decline from 2021.
  • Abbott Laboratories annual sg&a expenses for 2021 were $11.324B, a 16.79% increase from 2020.
Abbott Laboratories Annual SG&A Expenses
(Millions of US $)
2023 $10,949
2022 $11,248
2021 $11,324
2020 $9,696
2019 $9,765
2018 $9,744
2017 $9,182
2016 $6,736
2015 $6,785
2014 $6,530
2013 $6,372
2012 $6,735
2011 $7,365
2010 $10,376
2009 $8,406
Abbott Laboratories Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $2,895
2024-06-30 $2,936
2024-03-31 $2,959
2023-12-31 $2,724
2023-09-30 $2,723
2023-06-30 $2,740
2023-03-31 $2,762
2022-12-31 $2,973
2022-09-30 $2,731
2022-06-30 $2,757
2022-03-31 $2,787
2021-12-31 $3,048
2021-09-30 $2,767
2021-06-30 $2,726
2021-03-31 $2,783
2020-12-31 $2,570
2020-09-30 $2,302
2020-06-30 $2,276
2020-03-31 $2,548
2019-12-31 $2,413
2019-09-30 $2,440
2019-06-30 $2,434
2019-03-31 $2,478
2018-12-31 $2,359
2018-09-30 $2,377
2018-06-30 $2,466
2018-03-31 $2,542
2017-12-31 $2,477
2017-09-30 $2,115
2017-06-30 $2,150
2017-03-31 $2,440
2016-12-31 $1,673
2016-09-30 $1,628
2016-06-30 $1,737
2016-03-31 $1,698
2015-12-31 $1,655
2015-09-30 $1,666
2015-06-30 $1,727
2015-03-31 $1,737
2014-12-31 $1,666
2014-09-30 $1,595
2014-06-30 $1,649
2014-03-31 $1,620
2013-12-31 $1,260
2013-09-30 $1,612
2013-06-30 $1,714
2013-03-31 $1,786
2012-12-31 $1,159
2012-09-30 $1,920
2012-06-30 $1,814
2012-03-31 $1,842
2011-12-31 $2,905
2011-09-30 $4,239
2011-06-30 $2,762
2011-03-31 $2,850
2010-12-31 $2,797
2010-09-30 $2,673
2010-06-30 $2,743
2010-03-31 $2,162
2009-12-31 $2,225
2009-09-30 $2,086
2009-06-30 $2,024
2009-03-31 $2,071
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $196.757B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Koninklijke Philips (PHG) Netherlands $23.480B 17.97
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Baxter (BAX) United States $14.940B 9.72
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
Haemonetics (HAE) United States $3.938B 19.22
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Perrigo (PRGO) Ireland $3.547B 10.44
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00